anti-Myocyte Enhancer Factor 2B (MEF2B) Antikörper

The product of MEF2B is a member of the MADS/MEF2 family of DNA binding proteins. Zusätzlich bieten wir Ihnen Myocyte Enhancer Factor 2B Proteine (4) und und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
MEF2B 17259  
MEF2B 498607  
MEF2B 100271849 Q02080
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Myocyte Enhancer Factor 2B Antikörper auf antikoerper-online.de

Showing 10 out of 51 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Human Kaninchen Unkonjugiert WB WB Suggested Anti-MEF2B Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:62500  Positive Control:  293T cell lysate 100 μL 2 bis 3 Tage
$289.00
Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-MEF2B Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:62500  Positive Control:  293T cell lysate 100 μL 2 bis 3 Tage
$289.00
Details
Maus Kaninchen Unkonjugiert WB WB Suggested Anti-MEF2B Antibody Titration:  0.625ug/ml  ELISA Titer:  1:312500  Positive Control:  Human Lymphnode 100 μL 2 bis 3 Tage
$229.00
Details
Human Kaninchen Unkonjugiert ELISA, WB Western blot analysis of extracts from HT-29 cells, using MEF2B Antibody. The lane on the right is treated with the synthesized peptide. 100 μg 2 bis 3 Tage
$302.50
Details
Human Kaninchen Unkonjugiert ELISA, IHC, IHC (p), WB Human Brain, Cortex: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μL 11 bis 14 Tage
$484.00
Details
Human Kaninchen Unkonjugiert ELISA, ICC, IF, WB Western blot analysis of extracts from HT-29 cells, using MEF2B antibody. ABIN6274313 staining HT29 cells by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) antibody(Cat.# S0006), diluted at 1/600, was used as secondary antibody. 100 μL 11 bis 12 Tage
$390.77
Details
Maus Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$493.17
Details
Human Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$551.83
Details
Fledermaus Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$551.83
Details
Human Maus Unkonjugiert WB Western Blot analysis of MEF2B expression in transfected 293T cell line by MEF2B MaxPab polyclonal antibody.Lane 1: MEF2B transfected lysate(40.15 KDa).Lane 2: Non-transfected lysate. 50 μL 11 bis 12 Tage
$364.00
Details

Am meisten referenzierte anti-Myocyte Enhancer Factor 2B Antikörper

  1. Human Polyclonal MEF2B Primary Antibody für WB - ABIN2780724 : Gong, Tsai, Yan, Rubin: Cooperation between MEF2 and PPARgamma in human intestinal beta,beta-carotene 15,15'-monooxygenase gene expression. in BMC molecular biology 2006 (PubMed)

Weitere Antikörper gegen Myocyte Enhancer Factor 2B Interaktionspartner

Zebrafish Myocyte Enhancer Factor 2B (MEF2B) Interaktionspartner

  1. Mef2 controls skeletal muscle formation after terminal differentiation.

Mouse (Murine) Myocyte Enhancer Factor 2B (MEF2B) Interaktionspartner

  1. Mef2b deletion reduces germinal center (GC) formation in mice and identify MEF2B transcriptional targets in GC, with roles in cell proliferation, apoptosis, GC confinement, and differentiation. The most common lymphoma-associated MEF2B mutant (MEF2BD83V) is hypomorphic yet escapes binding and negative regulation by components of the HUCA complex and class IIa HDACs.

  2. Whereas MEF2A is absolutely required for proper myoblast differentiation, MEF2B, -C, and -D were found to be dispensable for this process.

  3. Calcineurein regulates skeletal muscle differentiation by activating MEF2 and MyoD transcription factors.

  4. Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo

Human Myocyte Enhancer Factor 2B (MEF2B) Interaktionspartner

  1. Studied expression of myocyte enhancer factor 2B (MEF2B) as part of the diffuse large (DLBCL) B-cell lymphoma 6 (BCL6) transcription complex in diffuse large B-cell lymphoma tissue samples and cell lines. Findings indicate MEF2B to be an essential component of the BCL6 gene transcriptional complex for the regulation of DLBCL growth thru promotion of BCL6 expression.

  2. Mef2b deletion reduces germinal center (GC) formation in mice and identify MEF2B transcriptional targets in GC, with roles in cell proliferation, apoptosis, GC confinement, and differentiation. The most common lymphoma-associated MEF2B mutant (MEF2BD83V) is hypomorphic yet escapes binding and negative regulation by components of the HUCA complex and class IIa HDACs.

  3. Although the mechanisms by which the D83V mutation in MEF2B promote oncogenesis in lymphoma cells remain to be elucidated, the observation that a mutation hotspot coincides with a conformation switch site on MEF2B reflects a remarkable convergence of tumor growth selection pressure and the physical/ chemical forces behind protein folding.

  4. The Apo structure of MEF2B reveals a largely preformed DNA binding interface that may be important for recognizing the shape of DNA from the minor groove side.

  5. MEF2B shows superior sensitivity and specificity than LMO2 and HGAL in the differential diagnosis of follicular lymphoma versus marginal zone lymphoma and is particularly useful in FL with plasmacytoid differentiation, which may have morphologic and immunophenotypic overlap with MZL.

  6. Expression of J chain immunoglobulin and MEF2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

  7. K4E, Y69H and D83V mutations decrease the capacity of MEF2B to activate transcription and decrease its effects on cell migration.

  8. Epstein-Barr Virus EBNA1 bound to host genes of high significance for B-cell growth and function, including MEF2B, IL6R, and EBF1.

  9. We conclude that MEF2B is a valuable marker of normal germinal center B cells, potentially useful in differential diagnosis of small B cell lymphomas.

  10. MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.

  11. MEF2B has a role in myogenic transformation of the epithelial to a myofibroblast phenotype

  12. The phylogenetic tree result shows that MEF2B may be original because of its difference of sequences and evolutional relation.

  13. 32% of diffuse large B-cell lymphoma and 89% of follicular lymphoma cases had somatic mutations in MLL2, and 11.4% and 13.4% of DLBCL and FL cases, respectively, had mutations in MEF2B

  14. Crystal structure of the MADS-box/MEF2S domain of human MEF2B bound to a motif of the transcriptional co-repressor Cabin1 and DNA at 2.2 A resolution

  15. myogenin and myocyte enhancer factor-2 expression are triggered by membrane hyperpolarization during human myoblast differentiation

  16. The crystal structure of a histone deacetylase 9 (HDAC9)/myocyte enhancer factor-2 (MEF2)/DNA complex reveals that HDAC9 binds to a hydrophobic groove of the MEF2 dimer.

  17. Study demonstrates that human intestinal cell BCMO1 expression is dependent on the functional cooperation between peroxisome proliferator-activated receptor-gamma and myocyte enhancer factor 2 isoforms.

  18. MEF2 proteins are an important component in Galpha13-mediated angiogenesis.

Cow (Bovine) Myocyte Enhancer Factor 2B (MEF2B) Interaktionspartner

  1. This study provides new evidence of the significant role played by Mef2B in the postnatal muscle growth and development in cattle, and indicates that Mef2B can be a promising molecular marker for carcass quality-related traits in adult cattle.

Myocyte Enhancer Factor 2B (MEF2B) Antigen-Profil

Protein Überblick

The product of this gene is a member of the MADS/MEF2 family of DNA binding proteins. The protein is thought to regulate gene expression, including expression of the smooth muscle myosin heavy chain gene. This region undergoes considerable alternative splicing, with transcripts supporting two non-overlapping loci (geneID:729991 and 100271849) as well as numerous read-through transcripts that span both loci (annotated as geneID:4207). Several isoforms of this protein are expressed from either this locus or from some of the read-through transcripts annotated on geneID:4207.

Genbezeichner und Symbole assoziert mit MEF2B

  • myocyte enhancer factor 2b (mef2b) Antikörper
  • myocyte enhancer factor 2B (MEF2B) Antikörper
  • myocyte enhancer factor 2B (Mef2b) Antikörper
  • AI451606 Antikörper
  • RSRFR2 Antikörper
  • si:ch211-125m10.1 Antikörper

Bezeichner auf Proteinebene für MEF2B

myocyte-specific enhancer factor 2B , MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B) , serum response factor-like protein 2

GENE ID SPEZIES
558073 Danio rerio
609739 Canis lupus familiaris
100568307 Pongo abelii
100568437 Macaca mulatta
17259 Mus musculus
498607 Rattus norvegicus
100271849 Homo sapiens
733675 Sus scrofa
100271851 Bos taurus
Ausgewählte Anbieter für anti-Myocyte Enhancer Factor 2B (MEF2B) Antikörper
Haben Sie etwas anderes gesucht?